Global High-Priority Regulatory Events — September 04, 2026

04-09-2026

Nixxy, Inc. received a Nasdaq deficiency notice on September 1, 2026, for failing to maintain a minimum bid price of $1.00 per share for 30 consecutive business days, triggering a 180-day grace period to regain compliance. Concurrently, the company announced the resignation of director Ashissh Raichura and the appointment of Joe Conlon as a new director and Audit Committee Chairman, while Elsa Sung was appointed CFO with an annual base salary of $169,800 and equity awards. The delisting risk and leadership changes create significant uncertainty, though the company intends to monitor its bid price and explore options to cure the deficiency.

• · Nasdaq notice does not result in immediate delisting; company has 180-day grace period ending around February 28, 2027.
• · If not compliant by then, company may qualify for a second 180-day period if it meets other listing standards and intends to effect a reverse stock split.
• · Ashissh Raichura's resignation was not due to any disagreement with the company.
• · Elsa Sung has over 20 years of financial experience, is a licensed CPA (inactive), and previously served as CFO of a Nasdaq-listed company.
• · Joe Conlon received 50,000 shares upfront and 50,000 shares annually vesting quarterly, plus $3,000 monthly.
• · CFO employment agreement includes one month severance if terminated without cause after 90 days, and four months severance upon change of control termination.

04-09-2026

LivePerson Inc. has filed an 8-K with the SEC indicating the completion of a merger or acquisition, as evidenced by the adoption of a Fifth Amended and Restated Certificate of Incorporation that reduces authorized shares to just 1,000 common shares. This drastic reduction in authorized capital is a hallmark of a going-private transaction or a reverse merger, where the company is being acquired and its stock will no longer trade publicly. The filing also includes standard provisions for director exculpation and indemnification, typical for a post-merger entity.

• · The company's authorized capital was reduced from a much larger number to just 1,000 shares of common stock, par value $0.01 per share.
• · The filing includes items 2.01 (Completion of Acquisition or Disposition of Assets), 3.01 (Notice of Delisting or Failure to Satisfy a Continued Listing Rule), 3.03 (Material Modification to Rights of Security Holders), 5.01 (Changes in Control of Registrant), 5.02 (Departure of Directors or Certain Officers), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 8.01 (Other Events).
• · The new certificate of incorporation eliminates personal liability of directors for monetary damages for breach of fiduciary duty, subject to standard exceptions.
• · The corporation is required to indemnify and advance expenses to directors and officers to the maximum extent permitted by Delaware law.

04-09-2026

Hemadri Cements Ltd, in voluntary liquidation w.e.f. July 14, 2025, has published its Annual Report for FY 2025-26 and convened the 44th AGM via video conferencing on September 29, 2026. The company reported zero net sales for FY 2025-26 (vs. ₹794.62 Lakh in FY 2024-25), a net loss of ₹126.67 Lakh (improved from a loss of ₹2,705.91 Lakh in the prior year), and a net worth of ₹2,821.93 Lakh (recovered from negative net worth of ₹380.42 Lakh in FY 2024-25). While the loss narrowed significantly and net worth turned positive, the company remains in liquidation with no operating revenue.

• · The company has been in voluntary liquidation w.e.f. July 14, 2025, with no operating revenue in FY 2025-26.
• · Loan funds reduced to ₹0 in FY 2025-26 from ₹2,012.02 Lakh in FY 2024-25, indicating debt repayment or write-off.
• · Fixed assets (net) reduced to ₹0 in FY 2025-26 from ₹1,090.42 Lakh in FY 2024-25, suggesting asset liquidation.
• · Net current assets stood at ₹1,439.56 Lakh in FY 2025-26 vs. ₹324.79 Lakh in FY 2024-25, a significant increase.
• · The liquidator's fee is proposed to be doubled from ₹50,000 to ₹1,00,000 per month due to unforeseen legal disputes in asset realisation.
• · No dividend has been declared for any of the last five years.
• · The company's registered office and factory are located in Vedadri Village, Krishna District, Andhra Pradesh.

04-09-2026

RE/MAX Holdings, Inc. filed Form 15 with the SEC on September 4, 2026, to terminate its registration and suspend its duty to file reports under Section 12(g) of the Securities Exchange Act of 1934. This action follows the completion of a merger on August 24, 2026, whereby the company was acquired by Real REMAX Group Inc. and its shareholders received cash for their shares, resulting in zero holders of record of Class A Common Stock.

• · The merger agreement was entered into on April 26, 2026 and amended on June 12, 2026.
• · The first merger (Merger Sub I into the Company) and subsequent merger (Company into Merger Sub II) both occurred on August 24, 2026.
• · The resulting entity, Wildlife Acquisition II LLC, is a wholly owned subsidiary of Real REMAX Group Inc.
• · The principal executive offices of the registrant are located at c/o Real REMAX Group Inc., 701 Brickell Avenue, 17th Floor, Miami, Florida 33131.
• · The Form 15 certification was signed by Leah Jenkins, Chief Accounting Officer.

04-09-2026

Talwalkars Better Value Fitness Ltd. is in liquidation. The NCLAT has set aside an NCLT order that had refused to grant certain reliefs and concessions to the successful auction purchaser (Ravikumar Gaurishankar Patel), who bought the company as a going concern for ₹15 Cr. The NCLAT held that the NCLT has jurisdiction under Section 60(5)(c) of the IBC to grant such reliefs and remanded the matter for fresh consideration. The appeal was allowed, but the underlying liquidation and the company's revival remain subject to further NCLT orders.

• · The corporate debtor was admitted into CIRP on 11.01.2021 and ordered into liquidation on 28.04.2022.
• · The e-auction was conducted on 16.08.2024 and the sale certificate was issued on 23.01.2025.
• · The NCLAT set aside the NCLT order dated 26.02.2026 and remanded the matter for fresh consideration of the reliefs/concessions sought by the appellant.
• · The NCLAT held that the NCLT has jurisdiction under Section 60(5)(c) of the IBC to grant reliefs/concessions necessary for implementing a going concern sale.
• · The appeal was allowed, but the company's revival remains subject to further NCLT orders.

04-09-2026

USA Rare Earth (Nasdaq: USAR) completed its combination with Serra Verde Group on September 3, 2026, creating a fully integrated rare earth and permanent magnet platform outside Asia. The deal combines Serra Verde's heavy-rare earth mining operation in Brazil with USA Rare Earth's processing, metallization, and magnet-making capabilities in the U.S., U.K., and France. While the merger positions the company as a Western-aligned supply chain leader, the combined entity faces significant execution risks including integration challenges, ramp-up delays at Serra Verde's Pela Ema facility, and substantial indebtedness under Serra Verde's Retained Finance Agreement.

• · Serra Verde's Pela Ema operation began production in January 2024 and is completing an advanced-stage optimization and commissioning program with ramp-up expected in Q3 2026.
• · Longer term, Serra Verde has potential to double run-of-mine production through a Phase 2 expansion.
• · Barbara Humpton will retire as CEO on October 1, 2026, and Thras Moraitis will succeed her.
• · Sir Mick Davis, former CEO of Xstrata plc, is joining the USA Rare Earth Board.
• · Advisors: Moelis & Company LLC (financial advisor to USAR), Latham & Watkins LLP (legal counsel to USAR), Goldman Sachs & Co. LLC (financial advisor to Serra Verde), White & Case LLP (legal counsel to Serra Verde), Allen Overy Shearman Sterling US LLP (legal counsel to Serra Verde shareholders).
• · Risks include: potential delays in optimization/commissioning and Phase II expansion at Pela Ema; political/economic/regulatory risks in Brazil and Switzerland; substantial indebtedness under Serra Verde's Retained Finance Agreement with restrictive covenants; risk that Offtake Agreement counterparty may be insufficiently capitalized; risk that proposed transaction with Carester SAS may not be consummated; limited operating history; volatility of stock price; and designation on Chinese export control list impacting raw material sourcing.

04-09-2026

CIE Automotive India Limited has acquired 69,40,000 equity shares of its wholly owned subsidiary CIE Hosur Limited on a rights basis for a total consideration of INR 120,75,60,000 (₹120,75,60,000). The funds raised by CIE Hosur will be used for repayment of intercorporate loans, capital expenditure, and general corporate purposes. CIE Hosur continues to be a wholly owned subsidiary of the company.

• · The acquisition is not a related party transaction; promoter/promoter group/group companies have no interest in CIE Hosur except through CIE Automotive India.
• · CIE Hosur Limited was incorporated on 6th August 2021 and is in the automotive industry.
• · The funds raised by CIE Hosur will be used for repayment of intercorporate loans, capital expenditure, and general corporate purposes.
• · No governmental or regulatory approvals were required for the acquisition.
• · The acquisition was completed on the date of the filing (4th September 2026).

04-09-2026

Indo Borax and Chemicals Limited, along with its person acting in concert (PAC) Zenrock Chemicals Private Limited, has launched an open offer to acquire up to 95,70,000 equity shares (25.79% of voting share capital) of Kronox Lab Sciences Limited at ₹157.27 per share, payable in cash. The offer is made under SEBI (SAST) Regulations and is not conditional on any minimum acceptance level. The tendering period is scheduled from October 15, 2026 to October 29, 2026, with payment completion by November 13, 2026.

• · The offer is made under Regulations 3(1) and 4 of SEBI (SAST) Regulations.
• · The offer is not conditional and is not subject to any minimum level of acceptance.
• · The Identified Date for determining public shareholders to receive the Letter of Offer is September 30, 2026.
• · The Draft Letter of Offer was filed with SEBI on September 4, 2026.
• · The last date for receipt of comments from SEBI on the Draft Letter of Offer is September 28, 2026.
• · The offer price may be revised upward at the discretion of the acquirer before the last working day prior to the tendering period.
• · The marketable lot for the offer is 1 (one) equity share.

04-09-2026

SEBI issued an adjudication order against Laxmi Chhugani for trading in illiquid stock options at BSE. The order was published on September 04, 2026, under the enforcement division of SEBI. No financial penalty or specific monetary amount is mentioned in the filing.

• · The adjudication order pertains to trading in illiquid stock options at BSE.
• · The order was issued by SEBI's Adjudication Officer (AO).
• · No penalty amount or specific violation details are provided in the filing.

04-09-2026

Annjana Dugar, Likhitta Dugar, Antariksh Dugar (Acquirers) together with Padam Dugar (PAC) made an open offer to acquire up to 6,54,966 equity shares (26% of voting capital) of Colinz Laboratories Limited at ₹54 per share, aggregating ₹3,53,68,164. However, only 6 shares were tendered in the offer, resulting in negligible acceptance and a post-offer acquirer shareholding of 49.57% (well below the 75.57% target). Public shareholding declined only marginally from 49.40% to 34.39% post-offer.

• · The open offer was open from August 7, 2026 to August 20, 2026, and payment was made on August 28, 2026.
• · Only 6 equity shares were tendered in dematerialized form, resulting in negligible acceptance.
• · The Acquirers are yet to consummate the Share Purchase Agreement dated June 18, 2026 for 8,70,500 shares (34.56% of voting capital).
• · Pre-offer public shareholding of 12,44,441 shares (49.40%) decreased to 12,44,435 shares (34.39%) post-offer, a reduction of only 6 shares.
• · The post-offer advertisement was published on September 4, 2026 in Financial Express (English), Jansatta (Hindi), and Pratahkal (Marathi).

04-09-2026

Global Asset Management Group, Inc. (KENS) entered into a Stock Purchase Agreement (Exhibit 2.1) on September 4, 2026, to acquire a target entity. The filing covers material agreement entry, completion of acquisition, and related disclosure items. No financial terms or performance metrics were disclosed in the filing.

• · Filing includes items 1.01 (Material Agreement), 2.01 (Completion of Acquisition), 2.03 (Direct Financial Obligation), 3.02 (Unregistered Sales of Equity), 3.03 (Material Modification to Rights of Security Holders), 5.02 (Departure of Directors or Principal Officers), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits).
• · The specific target entity and purchase price are not disclosed in the provided excerpt.

04-09-2026

National Standard (India) Limited (NSIL) has convened a meeting of equity shareholders on October 9, 2026, to approve a Scheme of Merger by Absorption with Lodha Developers Limited (LDL), as directed by the NCLT. Under the scheme, NSIL shareholders will receive 92 equity shares of LDL for every 1,000 shares held. NSIL has no ongoing business activity, and the merger aims to streamline the group holding structure and reduce overheads.

• · NCLT order dated August 6, 2026 directed the meeting of equity shareholders.
• · Meeting will be held via video conferencing on Friday, October 9, 2026 at 11:00 AM IST.
• · Cut-off date for e-voting eligibility is October 2, 2026; remote e-voting runs from October 6 to October 8, 2026.
• · The appointed date for the merger is July 1, 2024.
• · NSIL was incorporated on August 20, 1962; its equity shares are listed on BSE (Scrip Code: 504882).
• · LDL holds 73.94% of NSIL's share capital.
• · The scheme was revised on August 11, 2025 to exclude Sanathnagar Enterprises Limited (SEL).
• · Fairness opinions on the share exchange ratio were provided by Kotak Mahindra Capital Company Limited and Fedex Securities Private Limited.

04-09-2026

Roselabs Finance Ltd. has convened a meeting of equity shareholders on October 9, 2026, to approve a Scheme of Merger by Absorption with Lodha Developers Ltd. (formerly Macrotech Developers Ltd.) and National Standard (India) Ltd., as directed by the NCLT Mumbai Bench. Under the scheme, shareholders of Roselabs will receive 7 equity shares of Lodha Developers for every 1,000 shares held. The merger aims to streamline the group holding structure, reduce overheads, and simplify regulatory compliance, while Roselabs currently has no ongoing business activity.

• · The appointed date for the merger is July 1, 2024, or such other date as fixed by NCLT.
• · The original scheme included Sanathnagar Enterprises Ltd., but it was excluded in the revised scheme approved on August 11, 2025.
• · The meeting will be held via video conferencing/other audio-visual means on Friday, October 9, 2026, at 10:00 AM IST.
• · Remote e-voting runs from October 6, 2026 (9:00 AM) to October 8, 2026 (5:00 PM IST).
• · The cut-off date for determining e-voting eligibility is October 2, 2026.
• · The scheme has received observation letters from BSE and NSE dated December 30, 2025.
• · Roselabs Finance Ltd. is currently not engaged in any business activity.
• · National Standard (India) Ltd. has no material business activity or future business plans.

04-09-2026

AMR Resources Acquisition Corp. (Nasdaq: AMACU) announced that, effective September 8, 2026, holders of its IPO units may elect to separate the units into their component Class A ordinary shares and redeemable warrants. The units will continue to trade under 'AMACU', while the separated shares and warrants will trade under 'AMAC' and 'AMACW', respectively, on Nasdaq. This is a routine post-IPO administrative step and does not involve any business combination or financial results.

• · No fractional warrants will be issued upon separation; only whole warrants will trade.
• · Holders must contact their broker to instruct Continental Stock Transfer & Trust Company to separate units.
• · The company is a blank check company focused on the mineral resources sector.
• · The offering prospectus is available from BTIG, LLC or the SEC's website.

04-09-2026

Arcadia Biosciences, Inc. (RKDA) received a Nasdaq deficiency letter on August 31, 2026, for failing to meet the minimum $2,500,000 stockholders' equity requirement, reporting only $633,000 as of June 30, 2026. The company also does not meet the alternatives of market value of listed securities or net income from continuing operations. While the stock continues trading for now, Arcadia has until October 15, 2026, to submit a compliance plan, with no assurance of acceptance or successful regaining of compliance.

• · The company has 45 calendar days (until October 15, 2026) to submit a compliance plan to Nasdaq.
• · If Nasdaq accepts the plan, an extension of up to 180 calendar days from the date of the letter may be granted.
• · If the plan is not accepted, the company can appeal to a Nasdaq Hearings Panel, which would ordinarily stay any suspension or delisting pending a written decision.
• · The company also does not meet the alternative compliance standards of market value of listed securities or net income from continuing operations.

04-09-2026

Valuence Merger Corp. I (VMCUF) announced on September 3, 2026, that its board approved a one-month extension of the deadline to complete an initial business combination, moving the date from September 3, 2026 to October 3, 2026. This is the fifth of up to ten potential monthly extensions available, with the final possible extension date being March 3, 2027. The company deposited an additional $13,897.14 into its trust account to fund this extension.

• · The extension was approved by the board of directors on September 3, 2026.
• · The company has the right to extend the deadline monthly up to March 3, 2027.
• · The deposit amount of $13,897.14 was made into the trust account to support the extension.

04-09-2026

CONX Corp. completed its merger with HC2 Broadcasting Holdings LLC on September 1, 2026, following the execution of a Merger Agreement dated May 29, 2026. The transaction involved the conversion of the surviving entity into a Delaware limited liability company and the adoption of a new LLC Agreement. The filing details the governance structure, including board composition, tag-along and drag-along rights, and capital call provisions.

• · The Merger Agreement was entered into on May 29, 2026.
• · The Closing occurred on September 1, 2026.
• · CONX contributed all its interests in Merger Sub to CONX Broadcast Group, LLC on June 25, 2026.
• · The LLC Conversion was effected by filing a Certificate of Conversion and Certificate of Formation with the Delaware Secretary of State.
• · The LLC Agreement includes provisions for tag-along rights (Article 12), drag-along rights (Article 13), preemptive rights (Article 14), and capital calls (Section 3.5).
• · The Board of Directors includes a CONX Director designated by the CONX Investor (Section 5.2(a)(i)).
• · Certain confidential information has been redacted as indicated by '[****]'.

04-09-2026

Generation Income Properties, Inc. (GIPRW) filed a Form 25-NSE with the SEC on September 4, 2026, to delist its warrants from Nasdaq under Rule 12d2-2(a)(2). The delisting was filed by Nasdaq Stock Market LLC on behalf of the company, effective the same day. No financial figures or performance metrics are provided in this filing.

• · Delisting effective date: September 4, 2026
• · SEC file number: 001-40771
• · Company incorporated in Maryland, headquartered in Tampa, FL
• · Warrants are the specific security being delisted

04-09-2026

American Exceptionalism Acquisition Corp. A appointed Michael Teng to its board of directors and audit committee, effective September 1, 2026. The sponsor transferred 150,000 Class B shares to Mr. Teng in connection with his appointment. No other compensatory arrangements or transactions requiring disclosure under Item 404(a) were noted.

• · Mr. Teng was determined to be an independent director under SEC and NYSE rules.
• · He entered into joinder agreements for the Letter Agreement and Registration Rights Agreement, and a standard director indemnification agreement.
• · The company will reimburse Mr. Teng for reasonable out-of-pocket expenses incurred as a director.

04-09-2026

Pantages Capital Acquisition Corp received a Nasdaq deficiency notice on September 2, 2026, for failing to meet the Minimum Total Holders Requirement (at least 400 total holders) under Listing Rule 5450(a)(2). The company must submit a compliance plan by October 19, 2026, and may receive an extension of up to 180 days if the plan is accepted. The notice does not immediately affect trading, but failure to regain compliance could lead to delisting.

• · The company has until October 19, 2026, to submit a plan to regain compliance.
• · If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days from the notice date.
• · If the plan is not accepted, the company may appeal to a Hearings Panel.
• · The company is an emerging growth company and has elected not to use the extended transition period for new financial accounting standards.
• · The company has undergone multiple name changes: from Shepherd Ave Capital Acquisition Corp (July 2024), to AIFEEX NEXUS ACQUISITION CORP. (March 2025), to Pantages Capital Acquisition Corp (August 2025).

04-09-2026

Alchemy Investments Acquisition Corp 1 held an extraordinary general meeting on September 4, 2026, where shareholders approved a further adjournment. The meeting will reconvene on September 8, 2026, and the company continues to accept requests from shareholders to reverse previously submitted redemption elections. No financial results or material operational changes were disclosed.

• · Meeting was adjourned to Tuesday, September 8, 2026 at 12:00 p.m. Eastern Time.
• · Shareholders can reverse redemption elections by contacting their broker or Continental Stock Transfer & Trust Company.
• · The company's securities trade on the OTC market under symbols ALCUF (Units), ALCYF (Class A Ordinary Shares), and ALCWF (Warrants).
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.

04-09-2026

SoundHound AI completed its acquisition of LivePerson, creating a combined omnichannel conversational AI company with a customer base including 25 of the Fortune 100 and an IP portfolio of over 750 patents. The company also appointed John Collins as CFO, who previously served as CFO and interim CEO at LivePerson. The combined balance sheet is debt-free, and the company targets over $500M in future revenue from the existing customer base alone, while Gartner forecasts enterprise spend on agentic AI to reach $985 billion by 2030.

• · LivePerson common stock will cease trading on Nasdaq following the close.
• · Functional integration is underway, with combined product offerings rolling out in coming quarters.
• · John Collins holds both a JD and an MBA.
• · The combined company is debt-free, with LivePerson's outstanding debt retired at close.

04-09-2026

New Mountain Private Credit Fund filed Amendment No. 1 to its tender offer statement, reporting that third-quarter repurchases are estimated at approximately 3.44% of shares outstanding as of June 30, 2026. The Fund will honor all tenders for the quarterly repurchase period ending September 1, 2026, with final dollar values to be disclosed in October after determining net asset value as of September 30, 2026.

• · The tender offer was originally filed on August 3, 2026.
• · Repurchase price equals net asset value per share as of September 30, 2026.
• · Final repurchase dollar value will be disclosed in October 2026 in ordinary course filings.
• · Repurchase amounts are not yet final and are subject to finalization with the Fund's transfer agent.

04-09-2026

Archer Aviation Inc. filed an 8-K reminding holders that its public warrants (ACHR WS) will expire on September 16, 2026, at 5:00 p.m. New York City time. Trading of the warrants was halted by the NYSE on September 1, 2026, and will remain halted until trading is suspended before the open on September 15, 2026. Any unexercised warrants after the expiration date will become void with no further rights; the company's Class A common stock (ACHR) continues to trade normally on the NYSE.

• · The warrant expiration date is September 16, 2026, at 5:00 p.m. New York City time.
• · Warrant trading was halted on September 1, 2026, under NYSE Section 802.01D, and will remain halted until trading is suspended before the open on September 15, 2026.
• · The company's Class A common stock continues to trade on the NYSE under the symbol ACHR.
• · The warrant agreement was originally dated October 27, 2020, between Atlas Crest Investment Corp. and Continental Stock Transfer & Trust Company.

04-09-2026

SCWorx Corp. received a Nasdaq Staff letter on September 2, 2026, notifying it that it fails the minimum publicly held shares requirement (only 89,782 shares vs. 500,000 required). This adds to existing deficiencies in the minimum bid price and market value of publicly held shares requirements. The company intends to respond to the Nasdaq Hearings Panel by September 9, 2026, but faces significant risk of delisting.

• · The company had only 89,782 publicly held shares as of September 1, 2026, far below the 500,000 minimum.
• · The company also remains deficient in the minimum bid price requirement ($1.00) and the market value of publicly held shares requirement ($1,000,000).
• · A 1-for-12 reverse stock split effective August 3, 2026, reduced publicly held shares below the threshold.
• · The company must submit its views to the Nasdaq Hearings Panel by September 9, 2026.
• · Regaining compliance with the publicly held shares requirement will likely require issuing additional common stock, causing dilution.
• · If delisted, the stock would trade over-the-counter, reducing liquidity and price transparency.

04-09-2026

Matinas BioPharma received a third NYSE American noncompliance notice on August 31, 2026, for failing to meet the $2.0 million stockholders' equity continued listing standard (Section 1003(a)(i)), with reported equity of $1.8 million as of June 30, 2026. The company is already under a plan period through October 2, 2027, to regain compliance with all equity standards, and the stock remains listed and trading under 'MTNB' with a .BC indicator. While the notice has no immediate impact on trading, the company faces escalating delisting risk if it fails to meet the equity thresholds by the deadline.

• · The company has reported losses from continuing operations and/or net losses in its five most recent fiscal years.
• · Previous noncompliance notices were received on April 3, 2026 (Section 1003(a)(ii)) and June 26, 2026 (Section 1003(a)(iii)).
• · The NYSE American accepted the company's plan and granted a plan period through October 2, 2027.
• · If compliance is not achieved by the plan period deadline, delisting proceedings may be initiated.
• · The .BC indicator will be disseminated with the ticker symbol until compliance is regained.

04-09-2026

Inflection Point Acquisition Corp. VIII filed an 8-K reporting the consummation of its IPO and a private placement on August 31, 2026. The IPO of 28,750,000 units at $10.00 per unit generated gross proceeds of $287.5 million, and the private placement of 8,000,000 warrants at $1.00 each added $8.0 million. The company placed $287.5 million in a trust account and reported total assets of $289.7 million, but also recorded a shareholders' deficit of $(11.7) million due to offering costs and accumulated deficit.

• · The company has not yet commenced any operations; all activity relates to formation and the IPO.
• · Transaction costs totaled $19,545,458, comprising $5.0M cash underwriting fee, $13,687,500 deferred underwriting fee, and $857,958 other offering costs.
• · The company has a shareholders' deficit of $(11,658,824) as of August 31, 2026.
• · An affiliate (Inflection Point Fund I, LP) intends to commit up to $25.0M in a PIPE transaction for the initial business combination, but the commitment is subject to investment committee approval and the company may reduce or decline it.
• · The company may withdraw up to $1.0M per year from interest earned on the trust account for working capital.
• · The business combination must target a company with fair market value at least 80% of the trust account net assets, and the post-combination company must own or acquire 50% or more of the target's voting securities.

04-09-2026

Churchill Capital Corp XI (CCXI) filed an S-4 registration statement on September 4, 2026, for its business combination with Agility Robotics, Inc. The transaction involves a domestication from the Cayman Islands to Delaware, followed by a merger where Agility will become a wholly-owned subsidiary of CCXI, which will be renamed Agility Robotics, Inc. CCXI shareholders will vote on nine proposals, including the merger, stock issuance, and director elections. No financial metrics or performance data are disclosed in this filing.

• · The Merger Agreement was dated June 24, 2026.
• · CCXI will change its name to 'Agility Robotics, Inc.' after the business combination.
• · The Post-Closing Company will have a staggered board with directors elected for terms ending after the 2027, 2028, and 2029 annual meetings.
• · CCXI has not conducted any business activities other than those directed toward a business combination since its incorporation.
• · Merger Sub was formed solely for the transaction and has no assets or liabilities.
• · CCXI has no outstanding SEC comments or ongoing SEC review as of the filing date.

04-09-2026

Monroe Capital Income Plus Corporation completed a tender offer to repurchase 13,872,183 shares of its common stock at $9.77 per share, for a total cost of approximately $135.5 million. The offer, which expired on August 31, 2026, was oversubscribed with 17,848,959 shares validly tendered, resulting in a pro rata acceptance rate of approximately 77.7% of tendered shares. The high oversubscription indicates strong shareholder demand to sell at the offered price.

• · The filing is a final amendment (Amendment No. 1) reporting results of the tender offer, which expired at 11:59 P.M. Eastern Time on August 31, 2026.
• · The offer was initially filed with the SEC on August 3, 2026.
• · Shares repurchased represent approximately 77.7% of the validly tendered shares, meaning about 22.3% of tendered shares were not accepted due to oversubscription.
• · The company is a Maryland corporation with common stock at $0.001 par value per share.
• · Lewis W. Solimene, Jr. signed the filing as CFO and CIO.

04-09-2026

Klotho Neurosciences, Inc. (formerly Greenland Mines Ltd.) filed a Certificate of Designation for 359,324 shares of Series R Preferred Stock, which are convertible into common stock on a 1:1 basis only after stockholder approval is obtained. The shares carry no voting rights until such approval, and dividends are paid on an as-converted basis pari passu with common stock. The filing is a routine capital structure adjustment and does not involve a merger or acquisition.

• · Series R Preferred Stock has a liquidation preference equal to the as-converted common stock value plus any unpaid dividends.
• · Conversion is prohibited until stockholder approval is obtained, which also covers voting rights on an as-converted basis.
• · The Certificate of Designation was adopted by the Board on September 1, 2026.

04-09-2026

Quince Therapeutics received a Nasdaq notice on August 31, 2026, for failing to meet the minimum stockholders' equity requirement of $10,000,000, as its equity was ($35,324,000) as of June 30, 2026. The company has until October 15, 2026, to submit a compliance plan, with a possible extension to February 27, 2027. While the stock remains listed and trading under 'QNCX', the company is exploring alternatives, including a proposed name change to 'IRulya Therapeutics Inc.' and a transfer to the Nasdaq Capital Market under 'IRLA', but there is no assurance of regaining compliance.

• · The company has a negative stockholders' equity of ($35,324,000), which is $45.324 million below the required $10 million minimum.
• · The company filed a definitive proxy statement (DEF14A) on August 25, 2026, related to the proposed name change and transfer to the Nasdaq Capital Market.
• · If the plan is not accepted, the company retains the right to appeal, and the stock would remain listed until the appeal process concludes.
• · The company is evaluating various alternative courses of action to regain compliance, but there is no assurance of success.

04-09-2026

VineBrook Homes Trust, Inc. launched a tender offer to repurchase up to 909,090 shares at $33.00 per share, representing a 37.4% discount to its most recent NAV per share of $52.68 as of June 30, 2026. The offer provides limited liquidity to stockholders who have had no share repurchases since December 2022, but the Board makes no recommendation on whether to tender. While management remains optimistic about the company's long-term strategy, the offer size is capped and proration may apply if oversubscribed.

• · Share repurchases under the Share Repurchase Plan have been suspended since December 2022, with limited hardship exceptions.
• · The Board makes no recommendation to stockholders on whether to tender shares.
• · The offer price of $33.00 per share is 62.6% of the NAV per share of $52.68.
• · If more than 909,090 shares are tendered, proration will apply and not all tendered shares will be purchased.
• · The company may increase the number of shares accepted by up to 2% of outstanding shares (approximately 524,736 shares) without amending or extending the offer.
• · During the offer and for 10 business days after, the company will not accept any repurchase requests, including hardship requests.
• · The company does not anticipate listing shares on a national securities exchange at this time.

04-09-2026

Hawthorn Bancshares, Inc. completed its merger with FSC Bancshares, Inc. on September 3, 2026, adding Farmers State Bank's operations. The combined company now has total assets of approximately $2.2 billion and operates 27 banking locations across Missouri and one in Kansas. Customer conversion is expected in Q1 2027, and the press release contains only forward-looking statements with no current-period financial results to compare.

• · Merger effective date: September 3, 2026
• · Customer conversion anticipated during Q1 2027
• · Farmers State Bank customers will continue to use existing banking centers, website, and mobile app until conversion
• · Raymond James & Associates served as financial advisor to Hawthorn; Hunton Andrews Kurth served as legal counsel
• · Northland Capital Markets served as financial advisor to FSC; Stinson LLP served as legal counsel
• · Olsen Palmer LLC rendered a fairness opinion to FSC

04-09-2026

First Eagle Private Credit Fund filed a final amendment to its tender offer statement, reporting that its offer to purchase up to 621,102 shares expired on August 31, 2026. No shares were validly tendered and not withdrawn, resulting in zero shares purchased. The offer was conducted at net asset value per share as of September 30, 2026.

• · Tender offer expired at 11:59 p.m. Eastern Time on August 31, 2026.
• · Valuation date for net asset value per share was September 30, 2026.
• · This is a final amendment (SC TO-I/A) reporting results of the tender offer.

04-09-2026

Three Lions Acquisition Corp. closed its $100 million initial public offering of 10,000,000 units at $10.00 per unit on September 2, 2026. The SPAC will focus on target businesses in the sports, hospitality and leisure, and real estate sectors. A total of $100.5 million was placed in trust from the IPO and a simultaneous private placement.

• · Each whole warrant entitles holder to purchase one ordinary share at $11.50 per share.
• · EarlyBirdCapital has a 45-day option to purchase up to 1,500,000 additional units to cover over-allotments.
• · Registration statement was declared effective by the SEC on August 31, 2026.
• · The SPAC may pursue targets in any business, industry, or geography but expects to concentrate on sports, hospitality and leisure, and real estate.

04-09-2026

Irenic Acquisition Corp. dismissed CBIZ CPAs P.C. as its independent auditor on September 2, 2026, and engaged WithumSmith+Brown, PC on September 3, 2026. The change was not due to any disagreement, but the company disclosed a material weakness in internal control over financial reporting related to its financial statement review process as of June 30, 2026. Additionally, CBIZ CPAs' prior audit report included a going concern qualification, indicating substantial doubt about the company's ability to continue as a going concern.

• · CBIZ CPAs' audit report for the period from March 4, 2026 (inception) through March 6, 2026 included a going concern explanatory paragraph.
• · The material weakness relates to the company's financial statement review process not operating effectively to identify financial reporting errors.
• · WithumSmith+Brown, PC was engaged to audit the fiscal year ending December 31, 2026 and review the quarterly financial statements for the quarter ended September 30, 2026.
• · No consultations occurred between the company and Withum regarding accounting principles or disagreements prior to engagement.